| Supplemental Disclosure of Cash Flow Information |
Note 14 – Supplemental Disclosure
of Cash Flow Information
The supplemental cash flow information for
the nine months ended September 30, 2018 and 2017 (unaudited) is as follows:
| |
|
Nine Months Ended September 30, |
|
| |
|
2018 |
|
|
2017 |
|
| Cash paid for interest |
|
$ |
302,308 |
|
|
$ |
1,106,835 |
|
| Cash paid for income taxes |
|
$ |
20,000 |
|
|
$ |
506,313 |
|
| |
|
|
|
|
|
|
|
|
| Acquisition of Jamestown Regional Medical Center: |
|
|
|
|
|
|
|
|
| Cash |
|
$ |
- |
|
|
$ |
- |
|
| Inventory |
|
$ |
450,682 |
|
|
$ |
- |
|
| Prepaid expenses and other current assets |
|
$ |
310,385 |
|
|
$ |
- |
|
| Property and equipment |
|
$ |
7,347,468 |
|
|
$ |
- |
|
| Intangible assets |
|
$ |
486,716 |
|
|
$ |
- |
|
| Accrued expenses |
|
$ |
(193,966 |
) |
|
$ |
- |
|
| |
|
|
|
|
|
|
|
|
| Non-cash investing and financing activities: |
|
|
|
|
|
|
|
|
| Exchange of preferred stock for convertible debentures and warrants |
|
$ |
- |
|
|
$ |
10,734,336 |
|
| Cashless exercise of warrants |
|
$ |
4,619,150 |
|
|
$ |
- |
|
| Exchange of convertible debentures for convertible debentures and warrants |
|
$ |
- |
|
|
$ |
- |
|
| Exchange of debentures for Series I-2 Preferred Stock |
|
$ |
1,420 |
|
|
$ |
- |
|
| Services and severance settled through issuance of common stock |
|
$ |
- |
|
|
$ |
161,003 |
|
| Note payable, warrants, and accrued expenses settled through issuance of common stock |
|
$ |
- |
|
|
$ |
440,000 |
|
| Note payable and accrued expenses settled through issuance of Series J Preferred Stock |
|
$ |
250,000 |
|
|
|
- |
|
| Exchange of Series H Preferred Stock for debentures |
|
$ |
- |
|
|
$ |
2,695,760 |
|
| Series F Preferred Stock issued for business acquisition |
|
$ |
- |
|
|
$ |
174,097 |
|
| Debentures converted into common stock |
|
$ |
8,085,342 |
|
|
$ |
4,064,162 |
|
| OID from issuance of debentures |
|
$ |
1,920,000 |
|
|
$ |
- |
|
| Conversions of shares of Preferred Stock into common stock |
|
$ |
633,100 |
|
|
$ |
- |
|
| Conversions of shares of Series H Preferred Stock into common stock |
|
$ |
50,000 |
|
|
$ |
- |
|
| Deemed dividend for trigger of down round provision feature |
|
$ |
17,942,578 |
|
|
$ |
53,341,619 |
|
|